November 9-11, 2020 | Virtual Conference


Kimberly Witzmann, M.D.

Acting Deputy Director, OB, OGD, CDER

Dr. Kimberly Witzmann is a physician and is currently the Acting Deputy Director for the Office of Bioequivalence (OB) within the Office of Generic Drugs (CDER), at FDA. She is committed to making safe and effective generic drugs available to the American public. Her focus is complex generic drug products, including combination products, and she has been a key member of teams developing guidance documents and product-specific recommendations for FDA. She has spoken nationally at multiple meetings discussing development for complex generic combination products, including orally inhaled and nasal combination drug products.

Skip to content